Olema Pharmaceuticals, Inc. Insider Transactions
Olema Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Graham G. Walmsley
Director |
Sell | 700,761 @ $6.75 | $4.73 M | 0 | 12/17/2024 | 12/17/2024 | |
|
Graham G. Walmsley
Director |
Sell | 700,761 @ $6.75 | $4.73 M | 0 | 12/13/2024 | 12/18/2024 | |
|
Harmon Cyrus
Director |
Sell | 7,958 @ $8.66 | $68,916 | 764,319 | 12/11/2024 | 12/11/2024 | |
|
Harmon Cyrus
Director |
Sell | 179 @ $9.39 | $1,681 | 764,140 | 12/11/2024 | 12/11/2024 | |
|
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF |
Sell | 13,314 @ $8.66 | $115,299 | 598,633 | 12/11/2024 | 12/11/2024 | |
|
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF |
Sell | 300 @ $9.39 | $2,817 | 598,333 | 12/11/2024 | 12/11/2024 | |
|
Zojwalla Naseem
CHIEF MEDICAL OFFICER |
Sell | 14,202 @ $8.66 | $122,989 | 115,829 | 12/11/2024 | 12/11/2024 | |
|
Zojwalla Naseem
CHIEF MEDICAL OFFICER |
Sell | 320 @ $9.39 | $3,005 | 115,509 | 12/11/2024 | 12/11/2024 | |
|
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF. |
Sell | 17,950 @ $8.66 | $155,447 | 543,955 | 12/11/2024 | 12/11/2024 | |
|
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF. |
Sell | 406 @ $9.39 | $3,812 | 543,549 | 12/11/2024 | 12/11/2024 | |
|
Bohen Sean
CEO |
Sell | 55,907 @ $8.66 | $484,155 | 242,929 | 12/11/2024 | 12/11/2024 | |
|
Bohen Sean
CEO |
Sell | 1,267 @ $9.39 | $11,897 | 241,662 | 12/11/2024 | 12/11/2024 | |
|
Harmon Cyrus
Director |
Sell | 8,256 @ $9.37 | $77,359 | 772,277 | 12/10/2024 | 12/11/2024 | |
|
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF |
Sell | 12,452 @ $9.38 | $116,800 | 611,947 | 12/10/2024 | 12/11/2024 | |
|
Zojwalla Naseem
CHIEF MEDICAL OFFICER |
Sell | 13,283 @ $9.37 | $124,462 | 130,031 | 12/10/2024 | 12/11/2024 | |
|
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF. |
Sell | 16,803 @ $9.37 | $157,444 | 561,905 | 12/10/2024 | 12/11/2024 | |
|
Bohen Sean
CEO |
Sell | 52,328 @ $9.37 | $490,313 | 298,836 | 12/10/2024 | 12/11/2024 | |
|
Paradigm Biocapital Advisors LP
10 percent owner |
Sell | 1,870,499 @ $14.92 | $27.90 M | 4,720,482 | 08/01/2024 | 08/05/2024 | |
|
Paradigm Biocapital Advisors LP
10 percent owner |
Sell | 529,501 @ $14.92 | $7.90 M | 783,118 | 08/01/2024 | 08/05/2024 | |
|
Harmon Cyrus
Director |
Sell | 934 @ $15.55 | $14,524 | 751,283 | 07/30/2024 | 07/31/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Olema Pharmaceuticals, Inc. FAQ's
The list of insiders at Olema Pharmaceuticals, Inc. includes Harmon Cyrus, Graham G. Walmsley, Paradigm Biocapital Advisors LP, Bohen Sean, Kovacs Shane William Charles, Zojwalla Naseem, Myles David C..
Insiders have sold a total of 5.29 M Olema Pharmaceuticals, Inc. shares in the last 12 months for a total of 65.67 M sold.
The following insiders have sold Olema Pharmaceuticals, Inc. shares in the last 12 months: Harmon Cyrus ($1.18 M), Graham G. Walmsley ($26.91 M), Paradigm Biocapital Advisors LP ($35.80 M), Bohen Sean ($986,365), Kovacs Shane William Charles ($316,703), Zojwalla Naseem ($250,456), Myles David C. ($234,916),